Sakamoto Takashi, Fujiogi Michimasa, Matsui Hiroki, Fushimi Kiyohide, Yasunaga Hideo
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.
Department of Surgery, Tokyo Bay Urayasu Ichikawa Medical Center, 3-4-32 Todaijima, Urayasu, Chiba, 279-0001, Japan.
Heart Vessels. 2020 May;35(5):630-636. doi: 10.1007/s00380-019-01531-w. Epub 2019 Nov 2.
Nonocclusive mesenteric ischemia after cardiac surgery is a life-threatening complication requiring emergent intervention. However, because of its rarity, the clinical features and outcomes of nonocclusive mesenteric ischemia remain unknown. The present study aimed to clarify patients' backgrounds, clinical features and mortality of nonocclusive mesenteric ischemia after cardiac surgery, using a Japanese national inpatient database. We identified patients undergoing cardiac or thoracic aortic surgery between July 2010 and March 2017, using the Japanese Diagnosis Procedure Combination database. We calculated the incidence proportion of nonocclusive mesenteric ischemia and examined treatment options (bowel resection and interventional radiology) and patients' discharge status (in-hospital mortality and destination of discharge). We identified 221,900 eligible patients to find 568 (0.26%) patients with bowel ischemia in the same admission. Of these, 124 (0.06%) patients developed nonocclusive mesenteric ischemia, and in-hospital mortality after nonocclusive mesenteric ischemia was 77%. Treatment options for nonocclusive mesenteric ischemia included bowel resection alone (n = 34), interventional radiology (n = 15), or both (n = 15); 27, 10, and 8 patients died, respectively. Seven patients (5.6%) were discharged to home. Among 60 patients without bowel resection or interventional radiology, 50 patients died. In multivariable regression analysis, older age, preoperative hemodialysis, preoperative circulatory support, and hypothermic cardiopulmonary bypass were associated with NOMI. The present study showed that nonocclusive mesenteric ischemia after cardiac surgery was very rare. Mortality following nonocclusive mesenteric ischemia was very high even if patients underwent bowel resection or interventional radiology.
心脏手术后的非闭塞性肠系膜缺血是一种危及生命的并发症,需要紧急干预。然而,由于其罕见性,非闭塞性肠系膜缺血的临床特征和预后仍然未知。本研究旨在利用日本全国住院患者数据库,阐明心脏手术后非闭塞性肠系膜缺血患者的背景、临床特征和死亡率。我们使用日本诊断程序组合数据库,确定了2010年7月至2017年3月期间接受心脏或胸主动脉手术的患者。我们计算了非闭塞性肠系膜缺血的发病率,并检查了治疗选择(肠切除术和介入放射学)以及患者的出院状态(院内死亡率和出院去向)。我们确定了221,900名符合条件的患者,发现在同一住院期间有568名(0.26%)患者出现肠缺血。其中,124名(0.06%)患者发生了非闭塞性肠系膜缺血,非闭塞性肠系膜缺血后的院内死亡率为77%。非闭塞性肠系膜缺血的治疗选择包括单纯肠切除术(n = 34)、介入放射学(n = 15)或两者皆有(n = 15);分别有27、10和8名患者死亡。7名患者(5.6%)出院回家。在60名未接受肠切除术或介入放射学治疗的患者中,50名患者死亡。在多变量回归分析中,年龄较大、术前血液透析、术前循环支持和低温体外循环与非闭塞性肠系膜缺血相关。本研究表明,心脏手术后的非闭塞性肠系膜缺血非常罕见。即使患者接受了肠切除术或介入放射学治疗,非闭塞性肠系膜缺血后的死亡率仍然很高。